Heinz Müller
Patent Expert
Pharmaceutical
Swiss Federal Institute of Aquatic Science and Technology
Switzerland
Biography
Successful high-tech companies, such as life sciences companies, depend on the recovery of high product development costs. This pushes them into internationalization with a view to increasing turnover and recovery of investments. In particular, owing to the small size of Switzerland and thus the very limited market for such high-tech products, the country’s biotech companies tend to market their products outside the country of origin.
Research Interest
Given the Swiss economy’s high dependence on exports this may not seem surprising. However, other countries such as Germany are also export-oriented and probably face the same degree of internationalization in regard to their biotech sector. In contrast, the situation in countries such as the USA, which are not per se export-oriented, may be quite different.
